<![CDATA[In addition to varying expiratory airflow limitation, asthma is a diverse disease characterized by a history of respiratory symptoms (such as wheezing, shortness of breath, chest tightness, and coughing) that change over time and in intensity. Later, the restriction of airflow could become permanent. A prevalent condition in both adults and children, asthma has a high global morbidity, death, and economic cost. Now that asthma is acknowledged as a diverse illness, new clinical and laboratory studies have clarified our knowledge of the immunology that underlies the condition. It is now recognized that asthma is a heterogeneous, complex condition with a range of hereditary and environmental components, where focused medicines lead to greater asthma control. Previously, asthma was thought to be a single diagnosis with standardized treatments for all individuals. Physicians may recognize asthma by endotype and develop more specialized and efficient treatment plans to better manage their patient’s asthma by having a better understanding of the immunology of asthma. This comprehensive discussion of asthma immunology describes the causes and biomarkers now used in clinical practice, as well as the most advanced biological and specific treatments for asthma. From the review of this article, it can be concluded that articles were obtained with details of 18 articles containing information on Pathophysiology, Biomarkers, Immunology, and Treatments of Asthma.]]>
Copyrights © 2024
